Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale President and CEO sold 186,395 shares at an average $10.36 ($1,931,337)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale President and CEO sold 21,900 shares at $10.53 ($230,607)
  9. 4 Open-market sale SVP, CFO, Sec & Treasurer sold 12,450 shares at $10.53 ($131,099)
  10. 4 Open-market sale SVP & Chief Medical Officer sold 8,940 shares at $10.54 ($94,228)
  11. 4 Open-market sale Director sold 4,804 shares at $10.69 ($51,335)
  12. 4 Shares withheld for taxes President and CEO gave up 24,947 shares (to pay taxes)
  13. 4 Open-market buy 10% owner bought 162,014 shares at an average $14.40 ($2,332,713)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 29 · 579 filings